SOL SOLACI Performed a New Intervention During the Ecuador Sessions 2020

A new charitable case was featured at the Ecuador XL SOLACI Sessions 2020. At the CardioCentro Manta / Angiomanabí Clinic in Manta, Ecuador, physicians performed a successful closure of ductus arteriosus type A1 with an Amplatzer ADO I device (antegrade access). The patient was a 1-year old child admitted with a diagnosis of persistent ductus arteriosus. The case was sponsored by C.G MED.

Thus, SOLACI’s SOLidario (which means ‘solidary’ in Spanish) Program continues with its mission: facilitating the access to percutaneous and/or cardiovascular procedures to Latin American patients without the medical coverage or economic resources for them.

Below, the case presentation during the Ecuador Sessions 2020.

caso-solidario-jornadas-ecuador-2020

SOLACI’s SOLidario Program Against the COVID-19 Pandemic

Today, more than ever, the members of SOLACI’s SOLidario Program want our Latin American colleagues to know that we are in this together. As everyone knows, the primary purpose of this program is to grant our patients access to interventional procedures in renowned medical centers. Specialists who are SOLACI members perform such interventions in collaboration with other internationally famed experts.

The current situation would have been hard to imagine a short time ago. This pandemic represents an unimaginable challenge, but we will work together so that we can lead the resistance against the disease, directing our best efforts to aid those most vulnerable.

Dr. Marcelo Halac.
Head of SOLACI’s SOLidario Program.


About SOL SOLACI

programa solidario solaci

SOLACI’s SOLidario Program is a facilitator connecting the patient, the institution, the local scientific community, and the specialist with local suppliers in each country so that the performing team can count with the adequate supply of elements, drugs, and/or endovascular devices for a successful procedure.

Created by a group of adult and pediatric interventional cardiologists who are SOLACI members, SOLACI SOL seeks to facilitate the access to percutaneous therapeutic and diagnostic cardiovascular procedures, conducted in renowned medical centers by specialists who are SOLACI members, to patients in Latin America and the Caribbean who lack the medical coverage or economic resources for them.

In case of questions about SOLACI’s SOLidario Program, contact us at jornadas@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...